Methylprednisolone Recruiting Phase 2 Trials for Cerebral Radiation Necrosis Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03067753Monosialoganglioside Ganglioside in Cerebral Radiation Necrosis